AWAnne Walter

Anne Walter

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anne Walter has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Alexander Knuth

    Authors' Affiliations: 1Laboratory of Tumor Immunology, Department of Oncology, 2Department of Dermatology, and 3Department of Pathology, University Hospital Zurich, Zurich, Switzerland; and 4Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center, New York, New York

    1 shared publication
  • Bruno Schmid

    Authors' Affiliations: 1Laboratory of Tumor Immunology, Department of Oncology, 2Department of Dermatology, and 3Department of Pathology, University Hospital Zurich, Zurich, Switzerland; and 4Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center, New York, New York

    1 shared publication
  • Erika Ritter

    Department of Immunology, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY

    1 shared publication
  • Glen Kristiansen

    Authors' Affiliations: 1Laboratory of Tumor Immunology, Department of Oncology, 2Department of Dermatology, and 3Department of Pathology, University Hospital Zurich, Zurich, Switzerland; and 4Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center, New York, New York

    1 shared publication
  • Holger Moch

    Authors' Affiliations: 1Laboratory of Tumor Immunology, Department of Oncology, 2Department of Dermatology, and 3Department of Pathology, University Hospital Zurich, Zurich, Switzerland; and 4Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center, New York, New York

    1 shared publication
  • Maries van Den Broek

    Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland

    1 shared publication

Latest Publications

  • Open Access

    Cancer-Testis Antigens and Immunosurveillance in Human Cutaneous Squamous Cell and Basal Cell Carcinomas

    by Anne Walter, Marjam J. Barysch, Silvia Behnke, Piotr Dziunycz, Bruno Schmid, Erika Ritter, Sacha Gnjatic, Glen Kristiansen, Holger Moch, Alexander Knuth, et al.

    Purpose: Nonmelanoma skin cancer is the most common cancer and comprises basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). The incidence of SCC increases drastically in immunosuppressed individuals, suggesting a critical role of the immune system in controlling SCC. To find an explanation for the selective immunosurveillance of SCC, we investigated the expression of cancer-testis (CT) antigens and MHC class I (MHC-I) and the infiltration by immune cells in BCC and SCC. Experimental Design: We determined the expression of 23 different CT-antigens in 63 BCC and 40 SCC biopsies of immunocompetent and in 20 biopsies of immunosuppressed SCC patients by reverse transcription-PCR and immunohistochemistry. IgG responses to 36 tumor antigens were measured by Western blotting and ELISA. MHC-I expression and CD8+ T-cell infiltration were analyzed by immunohistochemistry in BCC and SCC of immunocompetent and immunosuppressed patients and in imiquimod-treated BCC patients. Results: We found expression of at least one CT-antigen in 81% of BCC and in 40% of SCC. We did not detect CT-antigen–specific serum IgG. Most SCC, but not BCC, expressed MHC-I and were infiltrated with CD8+ cells. Imiquimod-treated BCC expressed MHC-I and were infiltrated by CD8+ T cells. Conclusions: We propose that immunosurveillance controls SCC, but not BCC, because the latter lacks MHC-I. This fits with the increased incidence of SCC in immunosuppressed individuals and may explain the relatively low prevalence of CT-antigen expression in SCC as a result of CD8+ T-cell–driven immunoediting. Clin Cancer Res; 16(14); 3562–70. ©2010 AACR.